Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisBrain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorderActive, not recruitingPhase 32025-07-24NCT05071716

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bausch Health Americas, Inc.23

150 results · Page 1 of 6

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Bausch Site 102RialtoUnited States1
Bausch Site 103PeoriaUnited States1
Bausch Site 104CharlestonUnited States1
Bausch Site 105MilwaukeeUnited States1
Bausch Site 107DallasUnited States1
Bausch Site 109New YorkUnited States1
Bausch Site 110PhiladelphiaUnited States1
Bausch Site 111RichmondUnited States1
Bausch Site 113RichmondUnited States1
Bausch Site 114ClevelandUnited States1
Bausch Site 115La JollaUnited States1
Bausch Site 116New YorkUnited States1
Bausch Site 117BaltimoreUnited States1
Bausch Site 118New OrleansUnited States1
Bausch Site 119Redwood CityUnited States1
Bausch Site 120IndianapolisUnited States1
Bausch Site 122DallasUnited States1
Bausch Site 123DenisonUnited States1
Bausch Site 124LouisvilleUnited States1
Bausch Site 126MariettaUnited States1
Bausch Site 127MurrayUnited States1
Bausch Site 128TopekaUnited States1
Bausch Site 129ChandlerUnited States1
Bausch Site 130HoustonUnited States1
Bausch Site 132BostonUnited States1